These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7869057)

  • 41. Is fluorescent cystoscopy of cost/benefit/therapeutic value for carcinoma in situ of the bladder? Yes.
    Witjes JA
    J Urol; 2013 Jul; 190(1):19-20. PubMed ID: 23603096
    [No Abstract]   [Full Text] [Related]  

  • 42. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.
    Hermes B; Spöler F; Naami A; Bornemann J; Först M; Grosse J; Jakse G; Knüchel R
    Urology; 2008 Sep; 72(3):677-81. PubMed ID: 18455778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Normal" urothelium in patients with bladder cancer: a preliminary report from the National Bladder Cancer Collaborative Group A.
    Murphy WM; Nagy GK; Rao MK; Soloway MS; Parija GC; Cox CE; Friedell GH
    Cancer; 1979 Sep; 44(3):1050-8. PubMed ID: 476586
    [No Abstract]   [Full Text] [Related]  

  • 45. In situ transitional carcinoma and the non-specifically inflamed contracting bladder.
    Moloney PJ; Elliott GB; McLaughlin M; Sinclair AB
    J Urol; 1974 Feb; 111(2):162-4. PubMed ID: 4810755
    [No Abstract]   [Full Text] [Related]  

  • 46. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carcinoma in situ of the bladder with associated prostatic involvement.
    Thelmo WL; Seemayer TA; Madarnas P; Mount BM; Mackinnon KJ
    J Urol; 1974 Apr; 111(4):491-4. PubMed ID: 4856469
    [No Abstract]   [Full Text] [Related]  

  • 48. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary choriocarcinoma of the urinary bladder in association with undifferentiated carcinoma.
    Gallagher L; Lind R; Oyasu R
    Hum Pathol; 1984 Aug; 15(8):793-5. PubMed ID: 6540240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical evaluation of random biopsy of urinary bladder in patients with superficial bladder cancer.
    Taguchi I; Gohji K; Hara I; Gotoh A; Yamada Y; Yamanaka K; Okada H; Arakawa S; Kamidono S
    Int J Urol; 1998 Jan; 5(1):30-4. PubMed ID: 9535597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of transitional cell carcinoma of the prostate in bladder cancer patients: a prospective study.
    Wood DP; Montie JE; Pontes JE; Levin HS
    J Urol; 1989 Jul; 142(1):83-5. PubMed ID: 2733111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cystoscopic fluorescence detector for photodetection of bladder carcinoma with hematoporphyrin derivative.
    Lin CW; Bellnier DA; Prout GR; Andrus WS; Prescott R
    J Urol; 1984 Mar; 131(3):587-90. PubMed ID: 6700009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longitudinal study of bladder cancer with cytology and biopsy.
    Loening S; Narayana A; Yoder L; Slymen D; Weinstein S; Penick G; Culp D
    Br J Urol; 1978 Dec; 50(7):496-501. PubMed ID: 572723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Connective tissue stroma in bladder papillary transitional cell carcinoma, carcinoma in situ and benign cystitis.
    Ooms EC; Blomjous CE; Zwartendijk J; Veldhuizen RW; Blok AP; Heinhuis RJ; Boon ME
    Histopathology; 1986 Jun; 10(6):613-9. PubMed ID: 2426175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.
    Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T
    J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-grade transitional cell carcinoma of the pediatric bladder.
    Korrect GS; Minevich EA; Sivan B
    J Pediatr Urol; 2012 Jun; 8(3):e36-8. PubMed ID: 22105002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical significance of carcinoma in situ of the bladder and its association with overt carcinoma.
    Skinner DG; Richie JP; Cooper PH; Waisman J; Kaufman JJ
    J Urol; 1974 Jul; 112(1):68-71. PubMed ID: 4835082
    [No Abstract]   [Full Text] [Related]  

  • 58. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Formal discussion of "Clinical Observations on Sixty-nine Cases of in Situ Carcinoma of the Urinary Bladder".
    Koss LG
    Cancer Res; 1977 Aug; 37(8 Pt 2):2799. PubMed ID: 872106
    [No Abstract]   [Full Text] [Related]  

  • 60. Detection of transitional cell carcinoma in bladder by intravesical injection of monoclonal antibodies.
    Chopin DK; deKernion JB
    Urol Res; 1986; 14(3):145-8. PubMed ID: 3529570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.